Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Conant Optical (2276 HKG): Revenue Rise, Margins Expand in 2025; XR Lenses To Pave Way For Future

Conant Optical (2276 HKG): 1H26 Revenue and Margins Expand; XR Lenses Growth Story Slowly Unfolding

Shanghai Conant Optical (2276 HKG): Lens of Strong Fundamentals Makes the Growth Optics Visible

Conant Optical (2276 HKG): Growth Optics Sharp & Clear with Expanding Margins, Robust Sales in 1H25

Equity Capital Markets

Shanghai Conant Optical / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (2276 HK)</a> (2276 HK) announced the placement of 27M shares for subscription at HK$52 per share.</li>
<li>Company intends to use the proceeds majorly for construction of production line of XR supporting business, R&amp;D initiatives and working capital purpose.  </li>
<li>Given the current market price at which the stock is trading, the placement looks attractive. We continue to remain bullish on the name and the placement seems an opportune moment.</li>
</ul>



Shanghai Conant Optical (2276 HK) (2276 HK) announced the placement of 27M shares for subscription at HK$52 per share.
Company intends to use the proceeds majorly for construction of production line of XR supporting business, R&amp;D initiatives and working capital purpose.  
Given the current market price at which the stock is trading, the placement looks attractive. We continue to remain bullish on the name and the placement seems an opportune moment.


Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer